Androgen Deprivation Therapy With or Without Radium-223 Dichloride in Patients With Newly Diagnosed Metastatic Prostate Cancer With Bone Metastases: Hoosier Cancer Research Network GU13-170
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 26 Feb 2018
At a glance
- Drugs Bicalutamide (Primary)
- Indications Bone metastases; Prostate cancer
- Focus Therapeutic Use
- 20 Feb 2018 Planned primary completion date changed from 1 Jan 2018 to 1 Jun 2018.
- 20 Nov 2017 Status changed from recruiting to active, no longer recruiting.
- 10 Jun 2017 Biomarkers information updated